Community-Based Cohort Study of Hidden Malaria Infections, Diagnostic Gaps, & Mosquito Vector Dynamics in Odisha, India
NCT07770048 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000
Last updated 2026-08-18
Summary
The goal of this prospective cohort study is to understand the factors responsible for the persistence of malaria transmission in some areas despite intensive control efforts. The study will measure the prevalence and incidence of asymptomatic and sub-patent Plasmodium infections and examine the factors that contribute to persistent transmission among residents of malaria-endemic areas of Odisha, India.
The main questions the study aims to answer are: Do asymptomatic and sub-patent Plasmodium infections contribute to persistent malaria transmission in endemic areas of Odisha? What is the frequency of false-negative results and incorrect species identification when microscopy and rapid diagnostic tests (RDTs) are compared with PCR? How is malaria epidemiology changing over time across areas with different transmission patterns, including shifts in Plasmodium species? What is the prevalence of asymptomatic gametocyte carriers, and how might they contribute to ongoing transmission? What are the characteristics and distribution of mosquito vectors in and around households, and how do they relate to transmission patterns? Can novel host- and parasite-derived biomarkers improve the detection of malaria infections, including asymptomatic cases?
Participants will provide blood samples for malaria testing by microscopy, RDT and PCR. A subset will provide additional samples for biomarker analysis as part of a nested sub-study. Participants will be followed over time to measure malaria infection prevalence, incidence and changes in transmission patterns. They will also take part in household-level assessments, including surveys and mosquito vector monitoring around their homes.
Conditions
- Malaria, Asymptomatic Parasitaemia
Sponsors & Collaborators
-
National Institute of Allergy and Infectious Diseases (NIAID)
collaborator NIH -
Community Welfare Society Hospital (CWSH), Rourkela, Odisha, India
collaborator UNKNOWN -
ICMR-National Institute of Health Research, Bhubaneswar, Odisha, India
collaborator UNKNOWN -
London School of Hygiene and Tropical Medicine
lead OTHER
Principal Investigators
-
Samuel Wassmer, PhD · London School of Hygiene & Tropical Medicine, London
-
Sanjib Mohanty, MBBS MD · Community Welfare Society Hospital, Odisha, India
Eligibility
- Min Age
- 12 Months
- Max Age
- 69 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-05-02
- Primary Completion
- 2029-05-31
- Completion
- 2029-05-31
Countries
- India
Study Locations
More Related Trials
-
Antimalarial Drug Resistance in Mali
NCT00127998 ·Status: COMPLETED ·Phase: NA
-
Malaria Challenge in Healthy Volunteers
NCT01500980 ·Status: COMPLETED ·Phase: PHASE1
-
Malaria Transmission Studies in Mali
NCT01829737 ·Status: COMPLETED
-
Efficacy, Safety and Tolerability of Co-artemether in Non-immune Travelers
NCT00233337 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Evaluation of the STANDARD™ Q Malaria/CRP Duo Test
NCT04791800 ·Status: COMPLETED
-
Evaluation of Rapid Diagnosis Tests in Imported Malaria
NCT00451269 ·Status: COMPLETED
-
Study of Controlled Human Plasmodium Vivax Infection
NCT03377296 ·Status: COMPLETED ·Phase: NA
-
Plasmodium Falciparum Clearance Rates in Response to Artesunate in Eastern Cambodia
NCT01240603 ·Status: COMPLETED
-
Malaria Birth Cohort (MBC) in Agogo, Ghana
NCT04050566 ·Status: UNKNOWN
-
DSM265 Prophylaxis of Plasmodium Falciparum Malaria
NCT02562872 ·Status: COMPLETED ·Phase: PHASE1
-
A Pilot Study to Test Activity of Antimalarial Drugs Against an Induced Malaria Infection in Healthy Volunteers
NCT01055002 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Correlating Protection Against Malaria With Serum Profiles Against Plasmodium Falciparum Antigen Repertoires
NCT01214876 ·Status: COMPLETED
-
Determining a Tolerable Dose of Primaquine in G6PD-deficient Persons Without Malaria in Mali
NCT02535767 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of the Safety and Effectiveness of Two New Malaria Vaccines
NCT01003314 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Malaria Infection Diagnosed by Polymerase Chain Reaction (PCR) as a Means of Evaluating Pre-erythrocytic Candidate Malaria Vaccines
NCT00121823 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
VAC063C: A Study to Assess Repeat Blood-stage P. Falciparum Infection
NCT03906474 ·Status: COMPLETED ·Phase: NA
-
Longitudinal Analysis of Plasmodium Falciparum-Specific Immunity in Travelers and Immigrants From Malaria Endemic Areas to the United States
NCT02153996 ·Status: TERMINATED
-
Determining the Impact of Scaling up Mass Testing, Treatment and Tracking on Malaria Prevalence in Ghana
NCT04301531 ·Status: COMPLETED ·Phase: NA
-
Severe and Cerebral Malaria Investigated Through Host Metabolomics
NCT02451904 ·Status: COMPLETED
-
Dynamics of Subclinical Malaria: Preliminary Study
NCT03483571 ·Status: COMPLETED
-
Seasonal Malaria Chemoprevention With or Without Lipid-based Nutrient Supplement in Children Aged 6-59 Months in Mali
NCT03035305 ·Status: COMPLETED ·Phase: NA
-
Clinical Evaluation of Long-term Sequelae in Patients With Severe Plasmodium Falciparum Malaria
NCT06992297 ·Status: COMPLETED ·Phase: NA
-
Human Immunity to MSP-1 in Western Kenya
NCT00138372 ·Status: COMPLETED
-
MMV533 Plasmodium Falciparum Volunteer Infection Study
NCT05205941 ·Status: COMPLETED ·Phase: PHASE1
-
A Controlled Human Vivax Malaria Infection Study Through Inoculation of Infected Erythrocytes
NCT05071079 ·Status: RECRUITING ·Phase: NA